Augmenta Bioworks, Inc. logo

Augmenta Bioworks, Inc.

Profiling individual immunity for global therapeutics

1 employees · est. 2016 · Menlo Park, United States

VS
ImmusanT logo

ImmusanT

Pioneering advancements for celiac disease through innovative diagnostics and therapeutic solutions

est. 2011

ImmusanT is the older company (2016 vs 2011).

Side-by-Side Comparison

Augmenta Bioworks, Inc. ImmusanT
Founded
2016 2011 older
Headquarters
Menlo Park, United States Not tracked yet
Employees
1 Not tracked yet
Industry
Biotechnology, Health Care, Pharmaceutical Biotechnology, Health Care, Health and Wellness
Funding Stage
Not tracked yet Series Unknown
Total Funding
Not tracked yet $72.78M
Funding Rounds
Not tracked yet 4
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Immunotherapy, Therapeutics, Individual Immunity Profiling, Disease Research, Biomedical Technology, Immune System, Precision Medicine, Biopharmaceuticals Celiac Disease, Immunology, Diagnostics, Therapeutics, Gluten Tolerance, T-cell Test, Peptide-based Therapy, Therapeutic Vaccine, Cambridge, Massachusetts, Medical Research, Immune System, Immunotherapy, Healthcare Innovation
Website
augbio.com immusant.com
Augmenta Bioworks, Inc. logo

About Augmenta Bioworks, Inc.

Augmenta Bioworks, Inc. is a biotechnology startup based in the United States, founded in 2016. The company's slogan, "Profiling individual immunity for global therapeutics," reflects its mission to discover new therapeutics by leveraging the power of natural human immunity. Augmenta Bioworks' innov...

ImmusanT logo

About ImmusanT

ImmusanT is a biotechnology company founded in 2010 in Cambridge, Massachusetts. The company is at the forefront of pioneering advancements for celiac disease through innovative diagnostics and therapeutic solutions. ImmusanT leverages groundbreaking findings in immunology to enhance both diagnosis...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at Augmenta Bioworks, Inc. and ImmusanT — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at Augmenta Bioworks, Inc... and ImmusanT — by email.

Frequently Asked Questions

Augmenta Bioworks, Inc. — Profiling individual immunity for global therapeutics. ImmusanT — Pioneering advancements for celiac disease through innovative diagnostics and therapeutic solutions. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Augmenta Bioworks, Inc. has raised undisclosed funding while ImmusanT has raised $72.78M.
Augmenta Bioworks, Inc. and ImmusanT operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Augmenta Bioworks, Inc. with someone else

Start typing a company name or domain.

Related Comparisons

One analytics cookie (Google Analytics). Cookie Policy